交易 | 地址 | 数量 |
---|---|---|
eb5977...0531fa
|
ltc1qp...eaef0g
|
-
1.50208824 LTC
·
177.17 USD
|
eb5977...0531fa
|
ltc1q2...493nvt
|
+
0.109151 LTC
·
12.87 USD
|
eb5977...0531fa
|
ltc1qy...3rxqwz
|
+
1.39258661 LTC
·
164.25 USD
|
eb5977...0531fa
|
the-void |
+
0.00035063 LTC
·
0.04 USD
|
1d5290...f5e606
|
ltc1qe...w77d85
|
-
348.6591767 LTC
·
41,124.34 USD
|
1d5290...f5e606
|
ltc1qk...x059rm
|
+
0.34985503 LTC
·
41.26 USD
|
1d5290...f5e606
|
ltc1qe...w77d85
|
+
348.30900367 LTC
·
41,083.04 USD
|
1d5290...f5e606
|
the-void |
+
0.000318 LTC
·
0.03 USD
|
a14a61...183a0f
|
ltc1qe...w77d85
|
-
348.30900367 LTC
·
41,083.04 USD
|
a14a61...183a0f
|
ltc1qc...l6y9p4
|
+
1.06081238 LTC
·
125.12 USD
|
MEI Pharma completes $100 million private placement to purchase Litecoin as reserve asset, first publicly traded company to do so.
LD Capital创始人JackYi分析认为,加密货币牛市具有轮动上涨规律,山寨币可能在最后补涨。
MEI Pharma's stock surged over 33%, raising its market cap to $41.24 million. A strategic transformation led by Titan Partners Group and GSR is pushing MEI Pharma to establish a Litecoin treasury strategy.